Business/EarningsArticle

Vivos Therapeutics Reports 35% Revenue Increase in Q2 2026

Vivos Therapeutics announced a 35% increase in revenue for the second quarter of 2026.

PA

Priya Anand · Equities & Earnings Desk · 17 Aug 2026 · 1 min read

Share

Vivos Therapeutics Reports 35% Revenue Increase in Q2 2026

Vivos Therapeutics reported a 35% increase in revenue for the second quarter of 2026, according to the company's latest financial figures.

Additional financial metrics, net income figures, and detailed segmental breakdowns for the quarter were not immediately provided in the announcement.

Earnings Companies Profit

This article was produced with AI assistance and edited by a Finance Review Daily journalist.

Share this story

PA

Written by

Priya Anand

Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Market Snapshot

Delayed

EUR/USD1.1584▲ 0.15%GBP/USD1.3554▲ 0.13%USD/CHF0.8119▼ 0.04%BTC/USD63,120.01▲ 0.35%ETH/USD1,888.97▲ 0.69%XAU/USD4,390.61▲ 0.34%

Vivos Therapeutics Reports 35% Revenue Increase in Q2 2026

Market Snapshot

Related Reading

San Miguel Reports Core Profit Increase for First Half of 2026

HIAG Reports Strong First-Half 2026 Profit Growth

Iress Lifts Profit Outlook for H1 2026 Despite Slower Revenue Growth

GPT Group Reports Solid First-Half 2026 Growth as Shares Hold Flat

Corvex Misses Earnings and Revenue Estimates